EVP and Chief Medical Officer of Turning Point Therapeutics Inc (30-Year Financial, Insider Trades) Mohammad Hirmand (insider trades) sold 10,300 shares of TPTX on 01/05/2021 at an average price of $120.43 a share. The total sale was $1.2 million.
Turning Point Therapeutics Inc has a market cap of $5.88 billion; its shares were traded at around $122.000000 with and P/S ratio of 205.74. GuruFocus has detected 1 severe warning sign with Turning Point Therapeutics Inc. .
Directors and Officers Recent Trades:
- EVP and Chief Medical Officer Mohammad Hirmand sold 10,300 shares of TPTX stock on 01/05/2021 at the average price of $120.43. The price of the stock has increased by 1.3% since.
For the complete insider trading history of TPTX, click here
.